object
read
articl
reinforc
reader
knowledg
pathogenesi
common
cold
rational
current
potenti
therapi
common
cold
review
context
current
concept
pathogenesi
ill
data
sourc
studi
select
medlin
literatur
search
done
use
search
term
common
cold
rhinoviru
viral
respiratori
infect
search
restrict
english
languag
articl
select
review
titl
andor
abstract
suggest
content
relev
subject
review
bibliographi
select
articl
use
sourc
addit
literatur
result
recent
studi
suggest
host
respons
viru
import
contributor
pathogenesi
common
cold
inflammatori
mediat
especi
proinflammatori
cytokin
appear
import
compon
respons
present
attract
target
new
intervent
common
cold
therapi
current
avail
treatment
common
cold
limit
efficaci
specif
symptom
therapi
select
treat
specif
symptom
perceiv
bothersom
patient
viral
upper
respiratori
infect
account
approxim
ill
approxim
ill
young
infant
although
ill
gener
mild
selflimit
associ
enorm
econom
burden
lost
product
expenditur
treatment
common
cold
result
approxim
million
day
school
absenc
million
day
work
absenc
unit
state
annual
year
make
approxim
million
physician
visit
purchas
almost
billion
worth
overthecount
otc
cough
cold
medic
treatment
common
cold
symptom
recent
survey
repres
sampl
children
month
age
found
children
receiv
otc
cold
remedi
preced
day
pathogen
frequent
associ
common
cold
symptom
rhinovirus
import
pathogen
includ
coronavirus
respiratori
syncyti
viru
rsv
influenza
parainfluenza
adenovirus
may
caus
cold
symptom
howev
agent
frequent
caus
lower
respiratori
system
symptom
addit
nasal
symptom
characterist
common
cold
cold
occur
yearround
decreas
incid
summer
month
respiratori
viru
season
usual
begin
increas
incid
rhinoviru
infect
august
septemb
end
follow
spring
peak
rhinoviru
infect
april
may
period
increas
incid
diseas
caus
sequenti
rel
discreet
outbreak
differ
viral
pathogen
increas
incid
common
cold
symptom
associ
outbreak
howev
clinic
syndrom
usual
also
present
commun
epidem
caus
pathogen
rhinoviru
coronaviru
onset
common
cold
symptom
typic
occur
one
two
day
viral
infect
time
peak
symptom
gener
two
four
day
onset
ill
time
peak
symptom
one
day
later
coronavirus
rhinovirus
respiratori
syncyti
viru
recent
studi
suggest
subject
infect
rhinoviru
may
abl
detect
onset
symptom
earli
hour
viru
challeng
nasal
obstruct
rhinorrhea
sneez
present
earli
cours
cold
howev
sore
scratchi
throat
frequent
report
bothersom
symptom
first
day
ill
sore
throat
resolv
quickli
second
third
day
ill
nasal
symptom
predomin
cough
associ
approxim
cold
typic
becom
bothersom
symptom
day
ill
nasal
symptom
decreas
sever
usual
cold
last
week
although
last
week
viru
shed
persist
resolut
symptom
viru
may
cultur
subject
week
infect
averag
incid
common
cold
preschool
children
per
year
children
least
infect
per
year
incid
ill
decreas
age
averag
per
year
adulthood
incid
common
cold
young
children
affect
condit
increas
exposur
children
home
extens
contact
children
outsid
home
childcar
center
differ
incid
ill
group
children
decreas
length
time
spent
daycar
increas
howev
incid
ill
remain
higher
daycar
group
least
first
year
life
although
frequenc
common
cold
suggest
persontoperson
spread
must
fairli
effici
natur
transmiss
rhinoviru
appear
surprisingli
ineffici
transmiss
rate
report
studi
one
partner
marri
coupl
infect
rhinoviru
spous
document
suscept
viru
observ
acquisit
infect
anoth
studi
exposur
suscept
recipi
experiment
infect
donor
result
infect
rate
recipi
donorhour
exposur
viru
transmiss
rate
less
follow
brief
hr
exposur
virusinfect
subject
three
gener
mechan
common
cold
virus
might
spread
smallparticl
aerosol
largeparticl
aerosol
direct
contact
although
variou
common
cold
virus
may
presum
spread
mechan
rout
transmiss
may
effici
other
particular
virus
studi
experiment
rhinoviru
cold
human
volunt
suggest
direct
contact
effici
mechan
transmiss
viru
although
transmiss
larg
particl
aerosol
also
document
studi
natur
cold
found
treatment
hand
virucid
compound
significantli
reduc
transmiss
cold
rhinoviru
infect
subject
use
virucid
hand
treatment
studi
find
support
hypothesi
handtohand
transmiss
may
import
natur
set
transmiss
pathogen
associ
cold
less
well
studi
respiratori
syncyti
viru
appear
requir
close
contact
spread
experiment
set
spread
direct
contact
contamin
fomit
contrast
rhinoviru
rsv
influenza
appear
spread
persontoperson
small
particl
aerosol
regardless
rout
transmiss
studi
rhinoviru
infect
indic
contact
viru
nasal
mucosa
appear
import
initi
infect
small
inoculum
viru
appli
nasal
caviti
consist
result
infect
contrast
inocul
viru
oral
caviti
inoculum
requir
infect
rate
calcul
tissu
cultur
infecti
dose
nasal
rout
tissu
cultur
infecti
dose
oral
rout
conjunctiv
inocul
viru
also
effici
mechan
initi
rhinoviru
infect
presum
viru
reach
nasal
caviti
via
nasolacrim
duct
much
inform
relev
pathogenesi
common
cold
deriv
studi
subject
experiment
infect
rhinoviru
site
infect
rhinoviru
infect
gener
limit
mucosa
upper
respiratori
tract
pathogen
associ
common
cold
syndrom
eg
parainfluenza
virus
rsv
influenza
may
produc
differ
clinic
syndrom
infect
lower
respiratori
tract
follow
inocul
nasal
caviti
rhinoviru
first
detect
cultur
posterior
nasopharynx
cold
progress
viru
detect
anterior
site
one
nare
biopsi
nasal
mucosa
nasopharynx
experiment
cold
reveal
focal
infect
involv
rel
cell
ciliat
epitheli
cell
primari
cell
involv
although
noncili
cell
also
infect
appar
pauciti
rhinovirusinfect
cell
may
result
desquam
infect
cell
nasal
secret
abnorm
paranas
sinus
may
frequent
detect
computer
tomographi
magnet
reson
imag
natur
cold
experimentallyinduc
rhinoviru
cold
howev
studi
isol
viru
sinus
uncompl
cold
done
although
rhinoviru
isol
lower
respiratori
tract
experiment
infect
volunt
bronchoscopi
difficult
exclud
possibl
contamin
upper
respiratori
tract
promin
symptom
common
cold
rhinorrhea
nasal
obstruct
increas
vascular
permeabl
leakag
serum
nasal
mucosa
nasal
secret
major
contributor
symptom
contribut
glandular
secret
nose
rhinorrhea
becom
import
later
cours
ill
mechan
rhinoviru
infect
nasal
epithelium
result
increas
vascular
permeabl
increas
glandular
secret
clear
specimen
nasal
secret
human
volunt
infect
rhinoviru
contain
small
number
rhinoviru
infect
uninfect
ciliat
epitheli
cell
howev
examin
specimen
nasal
epithelium
light
electron
microscopi
reveal
consist
lesion
similarli
morpholog
chang
seen
monolay
human
nasal
epithelium
infect
rhinoviru
absenc
detect
histopatholog
rhinoviru
infect
led
suggest
host
respons
viru
may
play
primari
role
product
common
cold
symptom
earli
studi
host
respons
rhinoviru
infect
concentr
humor
immun
respons
viral
neutral
activ
appar
associ
iga
first
appear
nasal
secret
two
three
week
infect
time
neutral
activ
detect
serum
neutral
antibodi
serum
nasal
secret
associ
serotypespecif
protect
rhinoviru
infect
recent
studi
report
nonneutr
rhinovirusspecif
igg
iga
nasal
secret
third
day
rhinoviru
ill
evid
cellular
immun
respons
may
play
role
rhinoviru
pathogenesi
peripher
white
blood
cell
count
increas
infect
ill
subject
first
two
three
day
viru
challeng
increas
wbc
count
result
increas
concentr
neutrophil
infect
nonil
subject
chang
wbc
count
polymorphonuclear
leukocyt
respons
rhinoviru
infect
also
seen
nasal
mucosa
nasal
secret
chang
peripher
neutrophil
count
increas
polymorphonuclear
leukocyt
seen
infect
symptomat
subject
asymptomat
infect
individu
correl
lymphocyt
respons
rhinoviru
infect
symptomat
ill
less
clearli
character
conflict
data
effect
rhinoviru
infect
peripher
lymphocyt
count
modest
increas
tlymphocyt
concentr
report
nasal
mucosa
nasal
secret
rhinoviru
infect
blymphocyt
note
nasal
mucosa
role
inflammatori
mediat
focu
sever
recent
studi
rhinoviru
pathogenesi
similar
clinic
manifest
allerg
rhiniti
common
cold
prompt
repeat
attempt
establish
role
histamin
common
cold
sever
studi
report
detect
increas
histamin
nasal
secret
rhinoviru
infect
recent
studi
report
increas
histamin
level
normal
subject
subject
histori
allerg
rhiniti
follow
rhinoviru
inocul
prostaglandin
anoth
mast
cell
deriv
mediat
detect
nasal
secret
rhinovirusinfect
subject
studi
suggest
unlik
histamin
mast
cell
mediat
make
import
contribut
pathogenesi
rhinoviru
cold
kinin
bradykinin
lysyl
bradykinin
found
nasal
secret
volunt
rhinoviru
cold
experiment
induc
natur
acquir
concentr
time
cours
product
kinin
roughli
correl
sever
time
cours
symptom
subject
subject
infect
rhinoviru
develop
symptom
increas
nasal
secret
kinin
concentr
intranas
challeng
uninfect
volunt
increas
concentr
bradykinin
result
symptom
nasal
obstruct
rhinorrhea
sore
throat
role
kinin
pathogenesi
common
cold
symptom
less
clear
howev
light
failur
bradykinin
antagonist
allevi
common
cold
symptom
similarli
recent
studi
steroid
therapi
significantli
reduc
concentr
kinin
nasal
wash
effect
symptom
interleukin
also
recent
report
nasal
secret
symptomat
subject
experiment
rhinoviru
cold
kinin
concentr
protein
increas
decreas
symptom
sever
increas
decreas
concentr
nasal
secret
appear
directli
correl
sever
common
cold
symptom
intranas
challeng
normal
volunt
produc
influx
neutrophil
transient
increas
nasal
resist
airflow
signific
increas
nasal
symptom
score
compar
placebochalleng
subject
spite
data
demonstr
associ
symptom
inflammatori
mediat
role
mediat
pathogenesi
clear
specif
inhibitor
avail
use
clinic
trial
neurolog
respons
host
may
also
play
role
pathogenesi
rhinoviru
cold
studi
nasal
secret
shown
glandular
secret
nose
control
cholinerg
neurolog
pathway
contribut
rhinorrhea
especi
later
stage
ill
neurolog
pathway
also
appear
involv
reactiv
airway
diseas
associ
rhinoviru
infect
inflammatori
neuropeptid
substanc
p
play
role
form
noninfecti
rhiniti
howev
role
agent
common
cold
remain
examin
varieti
antivir
agent
studi
treatment
rhinoviru
infect
sever
drug
identifi
signific
vitro
antirhinovir
activ
test
vivo
howev
agent
ineffect
treatment
rhinoviru
infect
abraham
colonno
report
differ
rhinoviru
serotyp
share
cellular
receptor
subsequ
studi
shown
rhinovirus
one
attach
cell
via
two
differ
receptor
major
serotyp
bind
singl
receptor
subsequ
identifi
intercellular
adhes
molecul
blockad
receptor
site
cell
antibodi
receptor
bind
site
viru
solubl
shown
inhibit
viral
infect
vitro
potenti
treatment
common
cold
logist
maintain
appropri
concentr
either
protein
nasal
caviti
present
formid
obstacl
effect
use
agent
howev
studi
effect
agent
treatment
common
cold
progress
report
zinc
ion
inhibit
rhinoviru
replic
result
observ
numer
studi
efficaci
zinc
given
oral
lozeng
treatment
common
cold
symptom
spite
vitro
effect
zinc
viru
replic
detect
effect
zinc
lozeng
viru
replic
vivo
effect
zinc
symptom
inconsist
studi
report
dramat
effect
durat
cold
symptom
studi
find
effect
studi
may
directli
compar
sinc
differ
formul
zinc
use
variou
studi
howev
direct
correl
dose
zinc
given
clinic
efficaci
major
problem
interpret
studi
high
frequenc
side
effect
subject
receiv
zinc
difficulti
produc
placebo
distast
astring
activ
prepar
symptomat
therapi
remain
mainstay
treatment
common
cold
use
symptomat
therapi
avail
overthecount
direct
specif
symptom
rhinoviru
cold
subject
controversi
although
medic
found
effect
adult
studi
children
limit
inabl
accur
measur
common
cold
symptom
noncompli
subject
reason
conclud
effect
variou
prepar
similar
adult
children
use
medic
children
howev
must
balanc
potenti
side
effect
drug
topic
oral
adrenerg
agent
effect
nasal
decongest
compar
studi
done
common
cold
howev
gener
accept
topic
agent
potent
oral
drug
prolong
use
topic
adrenerg
agent
avoid
prevent
develop
rhiniti
medicamentosa
appar
rebound
effect
drug
discontinu
system
absorpt
imidazolin
eg
oxymetazolin
xylometazolin
rare
associ
bradycardia
hypotens
coma
system
side
effect
oral
adrenerg
agent
central
nervou
system
stimul
hypertens
palpit
antihistamin
effect
nasal
congest
treatment
rhinorrhea
primarili
blockad
cholinerg
stimul
glandular
secret
atropin
ipratropium
bromid
treatment
experiment
rhinoviru
cold
produc
small
decreas
rhinorrhea
nasal
mucu
weight
statist
signific
larger
studi
subject
natur
cold
ipratropium
produc
decreas
rhinorrhea
compar
placebo
ipratropium
approv
use
treatment
rhinorrhea
common
cold
common
side
effect
intranas
ipratropium
nasal
irrit
bleed
first
gener
antihistamin
use
mani
year
treatment
rhinorrhea
associ
common
cold
modest
statist
signific
effect
rhinorrhea
found
sever
small
studi
adult
although
studi
fail
detect
therapeut
effect
recent
larg
studi
experiment
cold
disclos
clemastin
fumar
reduc
rhinorrhea
approxim
compar
placebo
observ
subsequ
confirm
natur
cold
trial
second
gener
nonsed
antihistamin
effect
common
cold
symptom
limit
number
studi
observ
absenc
histamin
secret
subject
cold
similar
respons
ipratropium
antihistamin
suggest
effect
antihistamin
rhinorrhea
relat
anticholinerg
rather
antihistamin
properti
drug
major
sideeffect
associ
use
antihistamin
sedat
dri
eye
mouth
nose
sneez
frequent
report
symptom
common
cold
howev
rare
consid
bothersom
symptom
patient
antihistamin
effect
treatment
sneez
mechan
effect
antihistamin
sneez
cold
known
sore
throat
common
symptom
earli
cours
cold
frequent
first
symptom
notic
patient
sore
throat
associ
cold
gener
sever
often
describ
scratchi
throat
treatment
mild
analges
occasion
indic
particularli
associ
myalgia
headach
cough
cold
produc
sever
differ
mechan
treatment
direct
like
underli
caus
cough
patient
appear
due
nasal
obstruct
postnas
drip
cough
patient
promin
time
greatest
nasal
symptom
respond
treatment
antihistaminedecongest
combin
patient
cough
may
result
virusinduc
reactiv
airway
diseas
patient
may
cough
persist
day
week
acut
ill
may
benefit
bronchodil
therapi
cough
persist
resolut
cold
symptom
persist
associ
unremit
rhinorrhea
may
due
sinus
may
respond
antibiot
therapi
nonspecif
cough
suppress
either
codein
dextromethorphan
hydrobromid
frequent
use
howev
efficaci
agent
demonstr
common
cold
singl
studi
describ
modest
effect
nonsteroid
antiinflammatori
agent
acut
cough
cold
expector
guaifenesin
effect
antituss
agent
new
approach
examin
effect
combin
antiinflammatori
antivir
compound
report
recent
gwaltney
report
effect
treatment
establish
rhinoviru
infect
combin
naproxen
ipratropium
bromid
effect
combin
appear
greater
effect
usual
seen
avail
common
cold
therapi
recognit
direct
contact
import
mechan
transmiss
rhinoviru
led
effort
prevent
contamin
hand
infect
suscept
individu
varieti
chemic
compound
evalu
efficaci
inactiv
rhinoviru
environment
surfac
skin
although
agent
found
activ
practic
effect
hand
treatment
develop
facial
tissu
treat
combin
citric
acid
malic
acid
sodium
lauryl
sulfat
found
readili
inactiv
number
differ
rhinoviru
serotyp
evid
tissu
would
reduc
prevent
transmiss
viru
spite
potenti
util
product
never
made
avail
commerci
larg
number
rhinoviru
serotyp
long
recogn
obstacl
develop
vaccin
protect
rhinoviru
infect
recent
observ
rhinovirus
attach
cell
via
two
differ
receptor
suggest
potenti
prevent
infect
receptor
blockad
prophylaxi
experiment
rhinoviru
cold
monoclon
antibodi
major
cellular
receptor
delay
prevent
infect
prevent
rhinoviru
infect
also
attempt
varieti
antivir
agent
pirodavir
viru
capsid
bind
agent
appear
efficaci
prevent
rhinoviru
infect
although
detect
effect
treatment
establish
infect
similarli
effect
agent
prevent
rhinoviru
infect
effect
establish
infect
cost
side
effect
preclud
use
agent
prevent
rhinoviru
cold
rel
mild
symptom
short
durat
common
cold
present
challeng
attempt
provid
effect
treatment
current
avail
treatment
target
primarili
revers
observ
effect
viral
infect
limit
efficaci
newer
effort
seem
like
result
therapi
target
key
step
pathogenesi
upper
respiratori
symptom
effort
may
prove
benefici
treatment
common
cold
also
treatment
viral
respiratori
syndrom
complic
